Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robert E. Conway currently holds 6,000 shares of ARCA biopharma, Inc. (ABIO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert E. Conway has been a net buyer of ABIO stock. They have purchased $803.8K and sold $151.2K worth of shares.
Robert E. Conway's most recent insider trade was on May 20, 2024, when they sold 7,650 shares at $0.00 per share.
Robert E. Conway serves as Executive at ARCA biopharma, Inc. (ABIO). They have executed 30 insider transactions totaling $955.0K over their tenure at the company.
Robert E. Conway holds the position of Executive at ARCA biopharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Robert E. Conway has shown a buying trading pattern, with $803.8K in total purchases and $151.2K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Robert E. Conway was on Sep 23, 2021, when they sold $151.2K worth of ALPN shares. This transaction involved 15,000 shares at $10.08 per share.
Robert E. Conway currently owns 6,000 shares of ARCA biopharma, Inc. (ABIO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robert E. Conway's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robert E. Conway has 30 Form 4 filings on record as an insider at ARCA biopharma, Inc..
Set alerts for Robert E. Conway and 40,000+ other insiders.